Neflumozide

Neflumozide (HRP 913) is an orally active benzisoxazole derivative and a potent dopamine antagonist with antipsychotic activity. Neflumozide can be utilized in psychosis research[1].

Product Specifications

CAS Number

[86636-93-3]

Product Name Alternative

HRP 913

UNSPSC

12352005

Target

Dopamine Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/neflumozide.html

Smiles

O=C1NC2=C(N1C3CCN(CC3)CCCC4=NOC5=C4C=CC(F)=C5)C=CC=C2

Molecular Formula

C22H23FN4O2

Molecular Weight

394.44

References & Citations

[1]Stuart F, et al. The preclinical antipsychotic evaluation of HRP 913, a novel benzisoxazole derivative, Drug Development Research, Volume3, Issue3, 1983, Pages 233-243